Brainwave entrainment: what is documented, what is unclear, what is investigational

Put on headphones, open an app, and within seconds you can be listening to something the interface calls focus, or deep sleep, or meditation. Two slightly different tones in each ear, or a single pulsating rhythm, or both, layered under pleasant pads of sound. The promise is that your brain will entrain to the rhythm, enter the corresponding state, and stay there. Some products go further: flashing lights, 40 Hz pulses, a monthly subscription, testimonials about rewired cognition.

The premise is not wrong. It is also not what the most aggressive marketing says it is. Chapter 37 of Rife Frequency Healing separates the field into three buckets, and this page follows that split: what the evidence documents, what remains unclear, and what is genuinely investigational — meaning it is being tested right now under formal protocols, and is not in your pocket.

One distinction runs through all of it. An effect that shows up in an EEG trace is a measurement. An effect that matters to a person is a different kind of claim. The first does not deliver the second, and most of the confusion in this field lives in the gap between them.

The claim, and the mechanism underneath it

Every entrainment product rests on one documented phenomenon: the Frequency Following Response, or FFR. Expose a person to a rhythmic external stimulus — an audio pulse, a flashing light, a vibrating electrode — and neural populations in the sensory cortex tend to fire in time with that rhythm. Under the right conditions, the entrained activity spreads beyond primary sensory areas into broader networks, and the subject reports a subjective shift that corresponds loosely to the traditional EEG bands. That is the documented core, and it is the whole of the documented core.

Those bands supply the vocabulary of the field. Delta occupies roughly 0.5 to 4 Hz and predominates in deep sleep. Theta, 4 to 8 Hz, appears in drowsy and meditative states and during certain memory tasks. Alpha, 8 to 13 Hz, is the resting-awake band, strongest when the eyes are closed. Beta, 13 to 30 Hz, characterizes active waking thought. Gamma, above 30 Hz and particularly at 40 Hz, is associated with binding sensory information and certain attentional states.

Marketing draws a straight line from those associations to promised outcomes. Deliver a 10 Hz pulse and you will enter the alpha state. Deliver 4 Hz and you will sleep better. Deliver 40 Hz and you will concentrate, or repair DNA, or halt cognitive decline. The line sounds mechanical. It is not. The real relationship between entrainment and mental state is closer to influence than to command: a stimulus at a given frequency nudges cortical activity in that direction while it is running.

Whether that nudge produces a noticeable subjective effect, whether the effect persists after the stimulus ends, and whether it generalizes to tasks the person actually cares about are three separate empirical questions. Each has its own answer, and each answer is usually modest. Treating them as one question is the single most common error in this literature's popular retelling.

Three delivery methods, three different physics

Consumer entrainment products split into three main delivery methods, and they are not interchangeable. Each has its own physics, its own equipment requirement, and its own evidence profile.

Binaural beats were first described by the Prussian physicist Heinrich Wilhelm Dove in 1839 — often cited in popular literature, sometimes with the wrong first name. The setup requires stereo headphones: one frequency in the left ear, a slightly different frequency in the right. Play 200 Hz on the left and 210 Hz on the right and the listener perceives a beat at the difference frequency, 10 Hz, even though no 10 Hz signal physically exists anywhere. The beat is generated by the auditory brainstem processing the two inputs together. Played through speakers it collapses entirely, because both ears receive both frequencies and the interaural processing never occurs.

Isochronic tones are simpler. A single audible tone pulses on and off at the target rate — a 400 Hz tone switching on for 60 milliseconds and off for 40 milliseconds, ten times a second, produces a 10 Hz pulse train. Speakers work fine and headphones are optional. The stimulus is less subtle than a binaural beat and is often reported as more perceptible, sometimes uncomfortably so over long sessions.

Audio-visual stimulation adds rhythmic light. The mind machines of the 1980s and 1990s paired headphones with LED goggles that flashed at the session frequency; modern successors use screens or LED arrays. Visual entrainment tends to produce stronger cortical responses than audio alone, which is simultaneously its advantage and its principal safety concern.

A fourth delivery method matters to anyone reading this with a Rife machine on the desk: an electrical pulse through the skin, via contact pads or hand cylinders. It appears in the table below and gets its own section further down, because it is the case where evidence is most often borrowed from a modality it does not belong to.

What the meta-analyses measured, and what they did not

The clearest picture comes from the few meta-analyses that have aggregated a literature made almost entirely of small studies. Garcia-Argibay, Santed and Reales published one on binaural beats in Psychological Research in 2019, covering twenty-two studies of acute cognitive and affective outcomes. The pooled effect sizes were modest but non-trivial: Hedges' g of approximately 0.69 on anxiety measures, near 0.60 on pain measures, and about 0.35 on memory measures.

Read the nouns in that sentence carefully, because they carry the whole meaning. Those are effect sizes on scores — self-report questionnaires and laboratory task performance, recorded during or immediately after a listening session. They are not evidence that an audio track treats an anxiety disorder, a pain condition, or a memory disorder, and nothing on this page says they are. The authors themselves flagged substantial heterogeneity across studies, variable blinding quality, and short follow-up windows, and concluded that the long-term clinical utility of what they had measured remains unclear.

Chaieb, Wilpert, Reber and Fell reviewed the broader literature in Frontiers in Human Neuroscience in 2015 with a cautiously encouraging tone. Some findings survived across studies: acute movement on anxiety scales, short-term attention shifts. Others did not, particularly claims about memory enhancement or mood over days or weeks. A 2007 pilot by Helané Wahbeh and colleagues examined delta-frequency binaural beats and mood with a sample too small for conclusions, though its protocol documentation proved useful to later work.

The collective literature has visible limitations, and they are structural rather than incidental. Sample sizes are usually twenty to sixty participants. Blinding is difficult because listeners can often tell a real entrainment track from a sham. Outcome measures rely heavily on subjective self-report. And almost no study has tracked whether acute effects persist beyond the listening session at all.

So: documented, that rhythmic stimuli produce measurable acute changes on certain subjective and task measures under laboratory conditions. Not documented, any durable change in baseline brain function. And squarely not true, the marketing categories that sit on top. "Rewire your brain in seven days" misuses a real mechanism — neuroplasticity is real, but durable structural change in adult cortex requires sustained practice over weeks to months, while acute entrainment effects fade within minutes to hours. "Boost your IQ by 20 points" has repeatedly failed to appear in cognitive testing research; short-term gains on specific attention or memory tasks do not generalize to the composite scores intelligence tests measure, and do not persist outside the training context. "Genius frequencies" name a band that does not exist: gamma is associated with certain binding and attentional processes, but a 40 Hz tone does not make a listener a better problem-solver. And "DNA repair at 528 Hz" fails on the physics before it reaches the evidence.

40 Hz gamma: investigational, and what would settle it

A separate and scientifically more interesting line of work concerns 40 Hz gamma stimulation. It is also where the gap between research and consumer products is widest. In December 2016, Iaccarino and colleagues in Li-Huei Tsai's laboratory at MIT published in Nature (volume 540, pages 230-235) that optogenetic stimulation of fast-spiking interneurons at 40 Hz in a mouse model of Alzheimer's disease reduced amyloid-beta plaque load in the hippocampus, an effect subsequently reproduced with non-invasive 40 Hz flickering light. The proposed mechanism involved changes in microglial activity and the brain's waste-clearance pathways. Martorell and colleagues extended the work in Cell in 2019 (volume 177, pages 256-271) with combined 40 Hz audio and visual stimulation, and Murdock and colleagues published on glymphatic clearance in Nature in 2024 (volume 627, pages 149-156).

Replication has not been uniform, and this is the part that consumer marketing omits. Soula and colleagues, summarized on ALZFORUM, reported that seven days of daily 40 Hz light exposure in 5XFAD mice produced no significant change in microglial morphology and no detectable plaque reduction. A separate independent group, published in PubMed Central as PMC10408781, ran 5XFAD mice for one hour a day across five weeks at 24, 40 and 80 Hz and found no notable reduction in amyloid-beta in the visual cortex or hippocampus. Writing in The Transmitter in 2024, Brady Huggett summarized the position as: "Eight years on, nobody really knows why 40 Hz would work."

The human side is investigational in the formal sense. Cognito Therapeutics has an investigational device, Spectris, undergoing regulated clinical evaluation. The ADvance and OVERTURE trials, with results reported by Hajos and colleagues in 2024, examined it in cognitively impaired adults under investigational-device protocols. The book records, as of its first edition in 2026, that the pivotal HOPE trial was ongoing with primary results expected to report in late 2025, and that Spectris had not received FDA approval for any indication. That is a regulatory position with a date attached to it and it moves; anyone acting on it should check the current trial registry entries and the regulator's own record rather than this page or the book.

What would settle it is not mysterious. On the preclinical side, consistent independent replication of the plaque and microglial findings across laboratories and mouse lines. On the human side, a completed pivotal trial with published primary outcomes and a regulatory decision that turns on them. Neither has happened yet, which is exactly what the word investigational means.

One further point deserves stating plainly. A consumer product that invokes the Tsai laboratory's citations is making an implicit claim that its own output produces similar biological effects. No trial of that product supports that claim. A smartphone app playing a 40 Hz pulse is not the delivery system used in a controlled trial: the stimulation parameters, the intensity, the outcome measures and the regulatory standards are all different. Anyone following this research because a family member is affected by cognitive decline has a responsible path available — track the clinical trial literature, and ask a neurologist about participation in a registered trial. Buying a consumer device and hoping the marketing language maps onto the underlying science is not that path.

Rife machines with band-named presets

The four devices covered in the reference guide — Spooky2, TrueRife F-122, BCX Ultra and GB4000 — all ship with presets labeled by brainwave band. Spooky2's database contains entries for Alpha, Beta, Theta and Delta protocols. BCX Ultra users build custom low-frequency sequences. GB4000 offers the same capability through its manual entry interface. These presets typically run audio-range electrical pulses through contact pads or hand cylinders at the target band frequency.

The physics differs from binaural beats in a way that matters. A binaural beat is generated by the auditory brainstem processing two stereo inputs; the effect depends entirely on hearing. Rife-style electrical entrainment delivers a pulse through the skin, and the nervous system receives it via peripheral sensory afferents — cutaneous mechanoreceptors, and at higher intensities superficial nerve fibers — rather than through the auditory pathway. Whether peripheral rhythmic input entrains cortical oscillations with anything like the efficiency of auditory or visual stimulation is not well studied.

This is the bucket where the field's clearest error occurs. Users read a meta-analysis of binaural beats and assume its numbers carry over to a Theta preset running through hand cylinders. They do not. No published meta-analysis isolates cutaneous electrical entrainment at audio frequencies as its own category, and the handful of small studies in the area have not produced consistent findings. If it requires headphones, it is binaural beats; if it goes through your skin, it is a different thing with a different, thinner evidence base.

What would settle this one is a study design nobody has yet run at scale: cutaneous electrical pulsing isolated as its own condition, with EEG outcomes measured directly, adequate sham control, and a sample large enough to detect a modest effect. Until that exists, band-specific entrainment of cortical oscillators through contact pads is speculative for this delivery method — not disproven, unstudied.

What is not defensible in the meantime is paying a premium for "proprietary brainwave technology" in a device. There is no evidence base that would justify the surcharge, and a low-frequency pulse train is not a proprietary object.

Safety, and a realistic set of expectations

Photosensitive epilepsy is the largest documented risk in this field, and it applies specifically to visual and audio-visual devices using flashing light in the range of roughly 15 to 25 Hz. Approximately one person in ten thousand is susceptible, and susceptibility often becomes apparent in adolescence. The International League Against Epilepsy publishes detailed guidance on flicker-induced seizures, and any legitimate AVS product carries warnings in its documentation. Anyone with a personal or family history of seizures, or any history of unexplained loss of consciousness during light exposure, should not use visual entrainment without a neurologist's clearance. If a session produces disorientation, a metallic taste, unusual visual phenomena, or loss of awareness, stop immediately and seek medical evaluation.

Electrical entrainment through contact pads passes low-level currents across the body. Users with pacemakers, implanted cardiac defibrillators, deep-brain stimulators, cochlear implants, or spinal cord stimulators should consult the device manufacturer and their cardiologist or neurologist before any electrical session; most manufacturers advise against stimulation in the chest or near the implant. Entrainment devices are not designed for pediatric use and the evidence base in children is essentially absent, so children under 13 should not use them without pediatric medical supervision. The evidence base in pregnancy is thin; discuss any use with an obstetrician, particularly for visual and electrical modalities.

Two operational cautions round out the list. Sessions targeting delta or low theta ranges can leave a listener mildly disoriented for several minutes afterward, so do not drive, operate tools, or perform safety-sensitive tasks for at least twenty minutes after one. And start at fifteen to twenty minutes, increasing duration only after several tolerated shorter sessions — longer is not better, and some users report headaches or mild nausea from extended exposure, particularly with isochronic tones or visual stimulation.

As for what to expect: short-term changes in how a person rates their own attention, discomfort or state during a session are within what the meta-analyses actually measured. Anything past the end of the session is not. A seven-day program will not change a baseline. A thirty-day program may build a habit of daily stillness, in which case the habit rather than the frequency content is doing most of the work. And you do not need to pay a premium for the audio: free and low-cost sources deliver the same stimulus parameters as expensive ones, because the stimulus parameters are the only thing there is to deliver.

The line worth keeping is the one the chapter puts at its own opening. A session is a moment. A trait is a pattern. Entrainment can give you the first. It does not, on current evidence, give you the second.